Gleevec
List of products in the National Drug Code with proprietary name gleevec. This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome).
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 0078-0401 | Gleevec | Imatinib Mesylate | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 0078-0649 | Gleevec | Imatinib Mesylate | Tablet | Oral | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
| 66828-0030 | Gleevec | Novartis Pharma Produktions Gmbh |